German Electronic Equipment and Components Stock News

XTRA:SRT3
XTRA:SRT3Life Sciences

Assessing Sartorius (XTRA:SRT3) Valuation As High P/E Contrasts With Discounted Cash Flow Estimate

How Sartorius Stock Has Been Performing Sartorius (XTRA:SRT3) has seen mixed share performance, with the stock roughly flat over the past week, modestly positive over the past month, but showing negative returns over the past 3 months, year to date, and the past year. Over a longer horizon, Sartorius also records negative total returns across the past 3 years and past 5 years. This provides a sense of how recent trading levels compare with earlier periods for the stock. See our latest...
XTRA:KBX
XTRA:KBXMachinery

A Look At Knorr Bremse (XTRA:KBX) Valuation After Dividend Hike And Supervisory Board Changes

Knorr-Bremse (XTRA:KBX) drew fresh attention after announcing a 9% dividend increase to €1.90 per share for fiscal 2025 and confirming several Supervisory Board changes, including the addition of digitalization expert Dr. Christian Schlögel. See our latest analysis for Knorr-Bremse. After the dividend announcement and Supervisory Board changes, the share price closed at €99.05. The 1-year total shareholder return of 12.56% compared with the 3-year total shareholder return of 63.72% suggests...
XTRA:HAG
XTRA:HAGAerospace & Defense

European Value Stocks Priced Below Estimated Worth In May 2026

As the European markets navigate a complex landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index remained steady with only slight gains. Amid this economic climate, identifying stocks that are priced below their estimated worth becomes crucial for investors seeking opportunities in value investing.
XTRA:NEM
XTRA:NEMSoftware

Nemetschek (XTRA:NEM) Valuation Check After Strong Q1 Results And HCSS Acquisition

Nemetschek (XTRA:NEM) has drawn investor attention after reporting first quarter 2026 results, with double digit revenue and net income growth, a larger recurring revenue base, and the acquisition of Heavy Construction Systems Specialists. See our latest analysis for Nemetschek. Despite the strong first quarter update and the HCSS acquisition, Nemetschek’s share price has been under pressure, with a 90 day share price return of 19.64% and a year to date share price return of 31.56%. This has...
XTRA:BAS
XTRA:BASChemicals

Assessing BASF (XTRA:BAS) Valuation After Earnings Growth Buybacks And Portfolio Moves

BASF (XTRA:BAS) is back in focus after its first quarter 2026 earnings, where sales reached €16,020 million and net income came in at €927 million, with earnings per share edging higher year on year. See our latest analysis for BASF. The share price has moved up to €54.74, with a 30 day share price return of 7.46% and a 90 day gain of 17.39%. The 1 year total shareholder return of 29.90% suggests momentum has been building over both shorter and longer periods as investors react to higher...
XTRA:LHA
XTRA:LHAAirlines

A Look At Deutsche Lufthansa (XTRA:LHA) Valuation After Jet Fuel Price Surge And Capacity Cuts

Deutsche Lufthansa (XTRA:LHA) is back in focus after a report highlighted sharply higher European jet fuel prices linked to Middle East conflict, with the airline responding through capacity cuts and relatively high 2026 fuel hedging. See our latest analysis for Deutsche Lufthansa. The stock has been volatile, with a 1 day share price return of 3.07% and a 90 day share price return showing a 17.86% decline. The 1 year total shareholder return of 18.91% indicates longer term gains despite...
XTRA:NDX1
XTRA:NDX1Electrical

Nordex (XTRA:NDX1) Valuation Check After Strong Earnings And Delta4000 Progress

Why Nordex Stock Is Back in Focus After Its Latest Update Nordex (XTRA:NDX1) has moved back onto investors’ radar after first quarter 2026 earnings showed higher net income and earnings per share, along with fresh progress on its Delta4000 turbine platform and tower certifications. See our latest analysis for Nordex. The latest product updates and first quarter 2026 earnings have coincided with a share price of €48.52 and strong momentum, with a 90 day share price return of 39.91% and a one...
XTRA:AIXA
XTRA:AIXASemiconductor

A Look At AIXTRON’s (XTRA:AIXA) Valuation After Q1 Losses And AI Datacenter Order Momentum

AIXTRON (XTRA:AIXA) is back in focus after first quarter results showed sales of €59.38 million and a net loss of €21.94 million, while management highlighted strong optoelectronics orders linked to AI datacenter demand. See our latest analysis for AIXTRON. Despite the weak first quarter, AIXTRON's share price has surged recently, with a 30 day share price return of 41.17% and a 1 year total shareholder return of 267.80%. This suggests momentum has picked up as investors weigh AI linked order...
XTRA:DWS
XTRA:DWSCapital Markets

Is It Time To Reconsider DWS Group (XTRA:DWS) After Strong Multi‑Year Share Price Gains?

If you are wondering whether DWS Group GmbH KGaA is fairly priced right now, the key question is whether the current share price lines up with its underlying value. The stock last closed at €59.00, with returns of 3.5% over 7 days, 6.5% over 30 days, 4.6% year to date and 30.3% over 1 year, alongside a very large 3 year return and 135.5% over 5 years. Recent coverage has focused on DWS Group GmbH KGaA as an asset manager, which can affect how investors think about its fee resilience, cost...
XTRA:G1A
XTRA:G1AMachinery

Assessing GEA Group (XTRA:G1A) Valuation After Record 2025 Results And Higher Dividend

Record 2025 results bring GEA Group (XTRA:G1A) into focus GEA Group (XTRA:G1A) is back on many investors’ radars after reporting a record 2025, highlighting 9.1% organic order intake growth, a proposed dividend of €1.30 per share, and detailed guidance for 2026. See our latest analysis for GEA Group. Despite record 2025 results, GEA Group’s share price has eased recently, with a 7 day share price return of 4.27% and a 30 day share price return of 6.11%. However, longer term total shareholder...
XTRA:FTK
XTRA:FTKCapital Markets

Is It Time To Reassess flatexDEGIRO (XTRA:FTK) After A 16% Year To Date Decline?

If you are wondering whether flatexDEGIRO's share price still offers value at current levels, the key question is how its market price compares with its underlying fundamentals. The stock recently closed at €30.48, with returns of 0.2% over 7 days, 1.4% over 30 days, a 16.0% decline year to date, and 29.2% over the last year. Together, these figures give mixed signals about how the market is pricing its prospects and risks. Recent coverage has focused on flatexDEGIRO's position within online...
XTRA:8TRA
XTRA:8TRAMachinery

A Look At Traton (XTRA:8TRA) Valuation After Mixed Quarter Of Higher Orders And Weaker Earnings

Why Traton’s latest quarter is drawing fresh attention Traton (XTRA:8TRA) is back on investor radar after its first quarter update combined weaker headline earnings with an 18% jump in order intake and faster battery electric vehicle adoption. See our latest analysis for Traton. At a share price of €32.28, Traton has seen a 3.53% 1 day share price return and a 2.87% year to date share price return. Its 1 year total shareholder return of 16.44% and 3 year total shareholder return of 80.14%...
XTRA:MBG
XTRA:MBGAuto

A Look At Mercedes-Benz Group (XTRA:MBG) Valuation After Softer Q1 2026 Earnings And UK Legal Appeal

What the latest earnings and legal risks mean for Mercedes-Benz Group (XTRA:MBG) Mercedes-Benz Group (XTRA:MBG) has just paired softer first quarter 2026 results with an appeal against the UK Financial Conduct Authority’s car finance redress scheme, putting both earnings resilience and potential legal costs in focus for shareholders. For the quarter to March 31, 2026, the company reported sales of €25,497 million compared with €26,802 million a year earlier, and net income of €1,418 million...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care Refocuses Symvess Rights And Vascular Access Ambitions

Fresenius Medical Care (XTRA:FME) has amended its distribution agreement with Humacyte, Inc. regarding Symvess, an investigational acellular tissue engineered vessel. The revision realigns ex U.S. rights to Symvess and reshapes how the two companies coordinate on access to this advanced vascular product outside the United States. For you as an investor, this move sits at the intersection of medical technology and chronic kidney care, where XTRA:FME is a major global provider. Access to next...
XTRA:BMW
XTRA:BMWAuto

Is It Time To Revisit BMW (XTRA:BMW) After This Year’s Share Price Slide?

If you are wondering whether Bayerische Motoren Werke is attractively priced right now, the starting point is understanding how the current share price lines up against a grounded estimate of value. The stock closed at €77.92 most recently, with a 1.8% decline over the last 7 days, a 1.7% decline over 30 days, a 19.1% decline year to date, but a 9.9% gain over the past year. These mixed returns give you a picture of a share price that has shifted meaningfully over different time frames,...
XTRA:ALV
XTRA:ALVInsurance

Assessing Allianz (XTRA:ALV) Valuation After Recent Share Price Momentum And Analyst Targets

Allianz at a Glance: Recent Returns and Business Mix Allianz (XTRA:ALV) has drawn attention after a period where the share price shows a 1 day return of 1.1%, a 7 day return of 0.3%, and around 5.7% over the past month. For context, Allianz reports annual revenue of €113.2b and net income of €10.6b, with annual revenue growth of 9.1% and net income growth of 6%. The group operates across property casualty, life and health insurance, and asset management. See our latest analysis for...
XTRA:WCH
XTRA:WCHChemicals

A Look At Wacker Chemie (XTRA:WCH) Valuation After Strong Q1 EBITDA And Upgraded Sales Outlook

Wacker Chemie (XTRA:WCH) has caught investor attention after reporting Q1 EBITDA of €173 million, a 45% year-over-year increase, supported by its PACE cost program and upgraded full-year 2026 sales expectations. See our latest analysis for Wacker Chemie. Wacker Chemie’s share price has moved to €93.65, with a 30-day share price return of 14.14% and a 90-day return of 35.53%. The 1-year total shareholder return of 44.43% contrasts with weaker 3 and 5-year total returns, suggesting momentum has...
XTRA:HOT
XTRA:HOTConstruction

Assessing HOCHTIEF (XTRA:HOT) Valuation After Dividend Plans, Czech Airport Contract And Profit Update

HOCHTIEF (XTRA:HOT) has drawn fresh attention after confirming its upcoming dividend schedule, including the ex-dividend date, as well as securing a €220 million Czech airport modernization contract and reporting rising operational profits with unchanged FY25 guidance. See our latest analysis for HOCHTIEF. After HOCHTIEF confirmed its dividend timetable and the €220 million Czech airport project, the share price has moved to €457.2, with a 30 day share price return of 12.56% and year to date...
XTRA:P911
XTRA:P911Auto

Porsche Cayenne Coupé Electric Launch Tests P911 Valuation And Growth Story

Porsche has unveiled the all electric Cayenne Coupé at a world premiere event in Beijing. The launch extends electrification to one of Porsche's core SUV nameplates within the Cayenne range. The new model introduces updated design elements and e performance options in the premium SUV segment. For investors watching Dr. Ing. h.c. F. Porsche (XTRA:P911), the Cayenne Coupé Electric adds a fresh catalyst to a share price that last closed at €41.25. Over the past month the stock has returned...
XTRA:PAH3
XTRA:PAH3Auto

Porsche Automobil Holding (XTRA:PAH3) Valuation Check After €7.5b Shelf Registration Filing

Why Porsche Automobil Holding (XTRA:PAH3) just filed a €7.5b shelf Porsche Automobil Holding (XTRA:PAH3) has registered up to €7.5b in notes, a sizeable shelf that gives the company flexibility to issue debt as financing needs or portfolio opportunities arise. See our latest analysis for Porsche Automobil Holding. Despite the €7.5b shelf filing, Porsche Automobil Holding’s share price return over the past year has been weak, with a 23.47% year to date share price decline and a 56.22% five...
XTRA:RHM
XTRA:RHMAerospace & Defense

Is It Time To Reassess Rheinmetall (XTRA:RHM) After Recent Share Price Pullback?

Wondering if Rheinmetall at €1,355.80 is pricing in too much optimism or leaving room on the table for value focused investors like you? The stock is up 2.8% over the last week, but shows a 13.7% decline over 30 days, a 15.4% decline year to date, and a 13.5% decline over the past year, all following a very large 3 year gain and an even larger 5 year gain. Recent coverage has focused on Rheinmetall's position in defense and capital goods, which often draws attention whenever sector sentiment...